Eli Lilly värvar toppforskaren Kaj Blennow – ska leda Alzheimerprojekt

Eli Lilly rekryterar Kaj Blennow, en av Sveriges och världens främsta forskare inom Alzheimers sjukdom, till en post som Vice President of Neuroscience Biomarker Development.

We desire talent to come here, but are we genuinely welcoming them?

Sweden faces significant challenges in creating a truly inclusive environment that makes international professionals feel welcome, valued, and able to build mea...

Bioscience – Groundbreaking Research & Diagnostics: Gothenburg (2026)

Study: Popular diabetes treatment is not associated with thyroid cancer

Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by a...

Getinge and Neobiomics received Swecare's export awards

Two companies received awards during Swecare's annual conference.

”The importance of stratification in a statistician’s August kitchen”

Ingrid Lönnstedt writes about an experiment of her own at home and about what lessons can be learned from it, in a science column.

Vaccine skeptic David Geier to lead study on link to autism

The American government is to launch a study on whether vaccines cause autism – and has appointed a well-known vaccine skeptic to lead the analysis.

“Research is always a lot of failures and a few successes”

Gene therapies open up fantastic possibilities, but they are also extremely expensive to produce. Genenova aims to change that and make the treatments accessibl...

Merck Life Science A/S

Advanced workflow automation and scalable image analysis in spatial biology

ZEISS and Concept Life Sciences announce partnership.

Sustainability at Festo

On the Way to the Net Zero Era - New Sustainability Report published

Quality solutions for medical device R&D applications

From R&D to the quality assurance of series production in medical device manufacturing.

Rise and Scantox cease conducting animal testing in Stockholm

Access to in vivo toxicology services is significantly decreasing in the Stockholm area as Rise shuts down animal testing and Scantox reorganizes. ”The costs ar...

Leo Pharma to cut 200 jobs and reorganize

Danish Leo Pharma cuts down on staff in its global operations. Around 200 positions will be cut, while 50 will be moved to Poland.

Cost-efficient development of laboratory devices

8 ways to optimise development costs and speed up processes

High-tech companies are increasingly focusing on health

Tech companies have been taking an interest in healthcare for many years, and this interest seems to be increasing. “It’s not a sudden shift in trend, it’s more...

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

WuXi Biologics Germany GmbH

Göteborgsföretag med global ambition – Anyo Labs vinner mark i AI-racet

På femtio kvadratmeter i Göteborg sitter ett bolag som vill ta plats på en av världens hetaste tekniska arenor: AI-driven läkemedelsutveckling. ”Vi drivs mycket...

MSD köper Verona Pharma för 10 miljarder dollar

Läkemedelsjätten Merck & Co, känt som MSD utanför USA och Kanada, har ingått avtal om att förvärva Verona Pharma för cirka 10 miljarder dollar, motsvarande cirk...

Meribel Pharma Solna

QPS Netherlands B.V

In search of Marcel Proust's lost health

A great writer, but also a weak person and a hypochondriac. That has been the usual image of Marcel Proust. But the pediatrician and literary scholar Carl Lindg...

Norway rejects national life science strategy – sees no need

The Norwegian Arbeiderpartiet rejects a proposal that Norway should develop its own life science strategy.